Cypress Capital Management LLC Abb Vie Inc. Transaction History

Cypress Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $105,583 - $131,000	-800 Reduced 31.99%	1,701 $276,000
Q4 2021 Feb 22, 2022	SELL	$107.43 - $135.93 $20,841 - $26,370	-194 Reduced 7.2%	2,501 $339,000
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $21,042 - $23,442	200 Added 8.02%	2,695 $304,000
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $4,501 - $4,955	44 Added 1.8%	2,495 $270,000
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $197,280 - $266,350	2,451 New	2,451 $263,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Management LLC with notifications on news.